Thermo Fisher Scientific to Present at the 40th Annual J.P. Morgan Healthcare Conference

Thermo Fisher Scientific (NYSE: TMO), a leader in scientific services, will have CEO Marc N. Casper present virtually at the 40th Annual J.P.

Rhea-AI Summary

Thermo Fisher Scientific (NYSE: TMO), a leader in scientific services, will have CEO Marc N. Casper present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 8:15 a.m. (EST). The presentation will cover the company's business outlook and future financial expectations. Thermo Fisher reported annual revenues of approximately $40 billion and employs over 100,000 people globally. Investors can access the webcast via the company's website.

Argus Session date unavailable

-4.17% session move Open Argus

Details

News Market Reaction – TMO

The recorded move for TMO in the trading session of this news was -4.17%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., Jan. 4, 2022 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 40^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 8:15 a.m. (EST).  Among other topics, Mr. Casper will provide the company's current perspective on its business and expectations for future financial performance. 

You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team of more than 100,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Media Contact Information:
Ron O'Brien
Thermo Fisher Scientific
Phone: 781-622-1242
E-mail: ron.obrien@thermofisher.com

Investor Contact Information:
Rafael Tejada
Thermo Fisher Scientific
Phone: 781-622-1356
E-mail: rafael.tejada@thermofisher.com

 

View original content:https://www.prnewswire.com/news-releases/thermo-fisher-scientific-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301453254.html

SOURCE Thermo Fisher Scientific

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What will Marc N. Casper present at the J.P. Morgan Healthcare Conference?

Marc N. Casper will present Thermo Fisher's business outlook and future financial expectations.

When is Thermo Fisher Scientific's presentation at the J.P. Morgan Healthcare Conference?

The presentation is scheduled for January 11, 2022, at 8:15 a.m. (EST).

What is the stock symbol for Thermo Fisher Scientific?

The stock symbol for Thermo Fisher Scientific is TMO.

What is Thermo Fisher's annual revenue?

Thermo Fisher Scientific has an annual revenue of approximately $40 billion.

How many employees does Thermo Fisher Scientific have?

Thermo Fisher Scientific employs over 100,000 people worldwide.